Payer: Page 54


  • Image attribution tooltip
    UnitedHealth Group
    Image attribution tooltip

    UnitedHealth expects to 'successfully overcome' DOJ challenge to Change acquisition

    The company is bullish on completing its controversial acquisition of data analytics firm Change Healthcare, despite legal action from the Department of Justice to block the deal.

    By April 14, 2022
  • ACA marketplace premiums decline for third consecutive year, Urban Institute finds

    The marketplace is bucking the trend of sustained premium increases for job-based coverage, which provides insurance to a majority of nonelderly Americans.

    By April 13, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Medicare finalizes policy limiting coverage of Biogen Alzheimer's drug

    Treatment with Aduhelm would only be covered for patients enrolled in a clinical trial under the policy, which largely follows a draft proposal released in January.

    By Jonathan Gardner • Updated April 7, 2022
  • Centene CEO Michael Neidorff at the April 2016 opening of an office in Ferguson, Missouri.
    Image attribution tooltip
    Samantha Liss / Industry Dive/Healthcare Dive
    Image attribution tooltip

    Centene's former longtime leader Michael Neidorff dies

    Neidorff transformed the St. Louis-based insurer into a formidable player in the healthcare sector during his 26 years at the helm.

    By April 8, 2022
  • Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip

    Biden proposes rule to fix ACA's 'family glitch'

    The new regulation could help an estimated 200,000 uninsured people in the U.S. gain coverage, while 1 million could benefit from less expensive plans.

    By Susan Kelly • April 6, 2022
  • A preparation of Gilead Sciences' CAR-T therapy Yescarta is readied in a manufacturing laboratory.
    Image attribution tooltip
    Courtesy of Gilead Sciences
    Image attribution tooltip

    CAR-T treatment moves earlier as FDA widens approval of Gilead's Yescarta

    There are some obstacles to use. Yescarta is expensive, priced by Gilead at $373,000 per patient. Treatment is now widely covered by insurance, but the cost can still present hurdles for patients, depending on their coverage plans.

    By Ned Pagliarulo • April 6, 2022
  • Mass General Brigham hospital in Boston, Massachussets, is among JM Electrical's control system projects.
    Image attribution tooltip
    Permission granted by JM Electrical
    Image attribution tooltip

    Facing opposition, Mass General Brigham pulls back surgery center plans

    Although the system has withdrawn a proposal for three suburban surgery centers, it did secure recommendations for conditional approval for two other large-scale projects.

    By April 5, 2022
  • Image attribution tooltip
    CMS
    Image attribution tooltip

    Medicare Advantage plans will see 8.5% revenue bump in 2023

    CMS is not changing the risk adjustment calculation, which is meant to compensate plans for treating sicker patients. That's despite calls for an overhaul in the wake of allegations of abuse of the system.

    By April 5, 2022
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    Hospital E/M visit charges continued to rise in 2020, Fair Health finds

    Meanwhile, the percentage of claims for telehealth shot up from just 0.22% of all claims in 2019 to about 15% in 2020, as COVID-19 restrictions set in and patients worried of virus transmission.

    By March 30, 2022
  • Centene's headquarters in Clayton, Missouri, a suburb outside of St. Louis.
    Image attribution tooltip
    Samantha Liss/Healthcare Dive
    Image attribution tooltip

    Centene hit with $9M fine in Florida

    Florida is freezing enrollment in Centene's plans, according to a March 17 letter sent to the CEO of the Florida division, the Sunshine State Health Plan.

    By March 30, 2022
  • Image attribution tooltip
    UnitedHealth Group
    Image attribution tooltip

    UnitedHealth to buy home health business LHC for $5.4B

    A growing number of health insurers, private equity companies and hospitals are snapping up home health and hospice practices, with hopes for a substantial ROI.

    By March 30, 2022
  • Image attribution tooltip
    Diego Camargo/Healthcare Dive
    Image attribution tooltip

    Two years into the COVID-19 pandemic

    Hospitals overhauled their operations in COVID-19's early days. Now, two years into the pandemic, they are looking ahead at the future of their business, including revenue diversification and workforce stability.

    March 29, 2022
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Record 14.5M Americans signed up for ACA coverage this year

    But the generous subsidies that contributed to the increase in enrollment are temporary and set to expire at the end of the year absent congressional action.

    By March 24, 2022
  • Sarah London, Centene CEO
    Image attribution tooltip
    Permission granted by Centene
    Image attribution tooltip

    Centene appoints London as CEO, succeeding longtime leader Neidorff

    Sarah London specializes in data and technology and has quickly ascended the ranks at Centene, most recently rising to vice chairperson.

    By March 23, 2022
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    Labor union health fund targets hospital prices, looks to form purchasing coalition

    If successful, the coalition would bring together New York City's largest public employee union and the United Federation of Teachers. Together the group would represent about 540,000 people.

    By March 22, 2022
  • CMS admin Chiquita Brooks-LaSure speaks at HIMSS22 in Orlando
    Image attribution tooltip
    Rebecca Pifer/Healthcare Dive
    Image attribution tooltip
    HIMSS22

    Payer-to-payer data exchange rule to be published 'soon,' CMS head says at #HIMSS22

    CMS hasn't been enforcing stipulations that payers share patient data with competitors set out in regulations finalized two years ago. But that could change soon with a new rule.

    By March 15, 2022
  • A photo of a Biogen building
    Image attribution tooltip
    Permission granted by Biogen
    Image attribution tooltip

    Biogen and its partner rework terms of Aduhelm deal amid slow sales

    Instead of sharing global profits and losses, Eisai will receive royalties tied to net sales of the Alzheimer's drug. Biogen, meanwhile, said the amended deal should make it easier to "address market developments."

    By Jacob Bell • March 15, 2022
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Sutter Health defeats antitrust challenge in jury trial

    The federal jury in a class action suit rejected allegations that the California hospital system drove up healthcare costs in its markets through anti-competitive practices.

    By Susan Kelly • March 14, 2022
  • FTC
    Image attribution tooltip
    Carol Highsmith. (2005). "Apex Bldg." [Photo]. Retrieved from Wikimedia Commons.
    Image attribution tooltip

    Grassley pushes for PBM probe

    The senator wants FTC commissioners to come up with a more targeted focus for the study and suggested narrowing a review to the impact on consumers and their out-of-pocket costs.

    By March 14, 2022
  • Anthem plans to change name to Elevance

    It's the second name change for Anthem in the past decade. Prior to 2014, the company was known as WellPoint.

    By March 10, 2022
  • Medical groups say prior authorization burdens persisted during pandemic

    A new survey of doctor practices from the Medical Group Management Association found 98% of respondents wrestled with an increased or steady level of prior authorization requirements over the past year.

    By Susan Kelly • March 8, 2022
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    L.A. Care fined $55M after members faced barriers to timely care

    The fine is reportedly the largest in California history following an investigation that revealed serious systemic failures.

    By March 7, 2022
  • Concept image of insulin aspart with fake labeling
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Civica targets insulin in effort to produce cheaper drugs

    The nonprofit group announced ambitious plans to begin offering insulin at prices no higher than $30 per vial by early 2024.

    By Kristin Jensen • March 4, 2022
  • Image attribution tooltip
    Geisinger
    Image attribution tooltip

    Humana adds Cerner's Feinberg to board amid activist pressure

    Longtime Humana board member Marissa Peterson will not stand for reelection at the upcoming shareholder meeting, according to a proxy statement.

    By Updated March 9, 2022
  • Primary care physician turnover costs payers almost $1B every year, study finds

    Disruptions in care continuity when primary care providers leave their practices was a costly issue even before the pandemic, according to the American Medical Association.

    By Hailey Mensik • March 3, 2022